Kelcy Buday
Obstetrics & Gynecology · Farmington Hills, MINPI 1194341198
Payments from drug & device makers
Across 172 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$966
- Sumitomo Pharma America, Inc.$654
- Mayne Pharma Commercial LLC$453
- AbbVie$408
- Aspira Women's Health Inc$326
- Astellas Pharma US Inc$199
- plus $846 from 13 others
What the payments were for
- Food & beverage$3,60994%
- Education$2416%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 42 | $966 |
| Sumitomo Pharma America, Inc. | 28 | $654 |
| Mayne Pharma Commercial LLC | 24 | $453 |
| AbbVie | 20 | $408 |
| Aspira Women's Health Inc | 7 | $326 |
| Astellas Pharma US Inc | 6 | $199 |
| Shield Therapeutics Inc | 12 | $197 |
| Coopersurgical, Inc. | 6 | $127 |
| Millicent US Inc | 5 | $99 |
| Sage Therapeutics, LLC | 3 | $98 |
| Exact Sciences | 4 | $70 |
| Pfizer | 3 | $60 |
| Therapeuticsmd, Inc. | 3 | $48 |
| Avion Pharmaceuticals | 3 | $43 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Organon | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$114
How this compares
$3,851 in reported general payments places this provider in the 85th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VeozahFezolinetant | 12 | $6,342 |
| Estradiol | 21 | $2,575 |
| Procto-Med HcHydrocortisone | 22 | $229 |
| ValacyclovirValacyclovir Hcl | 13 | $162 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncVeozah | $199 | $6,34212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Other obstetrics & gynecology in Farmington Hills
- Amanda YancyFarmington Hills$15K
- Laura GruskinFarmington Hills$14K
- Haider MahdiDetroit$3.4M
- Andrew WagnerMidland$2M
- Jason BellAnn Arbor$548K
- Jacquelyn RobinsonSaginaw$539K
- Jouhaina MalehDearborn$524K
- Awoniyi AwonugaSouthfield$445K
- Rabbie HannaDetroit$421K
- David EisensteinDetroit$296K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.